BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26060116)

  • 1. Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy.
    Nakagawa N; Yagi H; Kato K; Takematsu H; Oka S
    Sci Rep; 2015 Jun; 5():11163. PubMed ID: 26060116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
    Hu H; Yang Y; Eade A; Xiong Y; Qi Y
    J Comp Neurol; 2007 Mar; 501(1):168-83. PubMed ID: 17206611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins.
    Nguyen H; Ostendorf AP; Satz JS; Westra S; Ross-Barta SE; Campbell KP; Moore SA
    Acta Neuropathol Commun; 2013 Sep; 1():58. PubMed ID: 24252195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
    Hu H; Yang Y; Eade A; Xiong Y; Qi Y
    J Comp Neurol; 2007 May; 502(2):168-83. PubMed ID: 17479518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage.
    Sudo A; Kanagawa M; Kondo M; Ito C; Kobayashi K; Endo M; Minami Y; Aiba A; Toda T
    Hum Mol Genet; 2018 Apr; 27(7):1174-1185. PubMed ID: 29360985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
    Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
    Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods.
    Kanagawa M
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex.
    Myshrall TD; Moore SA; Ostendorf AP; Satz JS; Kowalczyk T; Nguyen H; Daza RA; Lau C; Campbell KP; Hevner RF
    J Neuropathol Exp Neurol; 2012 Dec; 71(12):1047-63. PubMed ID: 23147502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
    Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP
    Nature; 2002 Jul; 418(6896):422-5. PubMed ID: 12140559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β2 and γ3 laminins are critical cortical basement membrane components: ablation of Lamb2 and Lamc3 genes disrupts cortical lamination and produces dysplasia.
    Radner S; Banos C; Bachay G; Li YN; Hunter DD; Brunken WJ; Yee KT
    Dev Neurobiol; 2013 Mar; 73(3):209-29. PubMed ID: 22961762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fukutin deficiency in the developing mouse brain.
    Chiyonobu T; Sasaki J; Nagai Y; Takeda S; Funakoshi H; Nakamura T; Sugimoto T; Toda T
    Neuromuscul Disord; 2005 Jun; 15(6):416-26. PubMed ID: 15907289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of early defects in Cajal-Retzius cell localization during brain development in a mouse model of dystroglycanopathy.
    Booler HS; Pagalday-Vergara V; Williams JL; Hopkinson M; Brown SC
    Neuropathol Appl Neurobiol; 2017 Jun; 43(4):330-345. PubMed ID: 28039900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degree of Cajal-Retzius Cell Mislocalization Correlates with the Severity of Structural Brain Defects in Mouse Models of Dystroglycanopathy.
    Booler HS; Williams JL; Hopkinson M; Brown SC
    Brain Pathol; 2016 Jul; 26(4):465-78. PubMed ID: 26306834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of expression of dystroglycan may protect the heart.
    Brancaccio A
    Neuromuscul Disord; 2013 Nov; 23(11):867-70. PubMed ID: 23911074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.
    Zhang P; Yang Y; Candiello J; Thorn TL; Gray N; Halfter WM; Hu H
    Matrix Biol; 2013 Apr; 32(3-4):196-207. PubMed ID: 23454088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain.
    Satz JS; Ostendorf AP; Hou S; Turner A; Kusano H; Lee JC; Turk R; Nguyen H; Ross-Barta SE; Westra S; Hoshi T; Moore SA; Campbell KP
    J Neurosci; 2010 Oct; 30(43):14560-72. PubMed ID: 20980614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.
    Radmanesh F; Caglayan AO; Silhavy JL; Yilmaz C; Cantagrel V; Omar T; Rosti B; Kaymakcalan H; Gabriel S; Li M; Sestan N; Bilguvar K; Dobyns WB; Zaki MS; Gunel M; Gleeson JG
    Am J Hum Genet; 2013 Mar; 92(3):468-74. PubMed ID: 23472759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies.
    Muntoni F; Torelli S; Wells DJ; Brown SC
    Curr Opin Neurol; 2011 Oct; 24(5):437-42. PubMed ID: 21825985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaches of the pial basement membrane are associated with defective dentate gyrus development in mouse models of congenital muscular dystrophies.
    Li J; Yu M; Feng G; Hu H; Li X
    Neurosci Lett; 2011 Nov; 505(1):19-24. PubMed ID: 21970971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
    Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
    Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.